Targeting the host inflammatory response in traumatic spinal cord injury

Current Opinion in Neurology

Volumn 15, Issue 3, 2002, Pages 355-360

  Bethea, John R ^a   Dietrich, W Dalton ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL TRANSFER; DISEASE ASSOCIATION; HUMAN; INDUCED HYPOTHERMIA; INFLAMMATION; NERVE FIBER REGENERATION; NEUROPROTECTION; OXIDATIVE STRESS; REVIEW; SPINAL CORD INJURY; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; HYPOTHERMIA, INDUCED; INTERLEUKIN-10; MYELITIS; NERVE DEGENERATION; NERVE REGENERATION; NITRIC OXIDE; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036264280     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200206000-00021     Document Type: Review

References (74)

1. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis Rats
2. Upregulation of nerve growth factor following cortical trauma
3. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 β in the striatum of young and middle-aged mice
4. Central nervous system initiated inflammation and neurotrophins in trauma: IL-1β is required for the production of ciliary neurotrophic factor
5. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
6. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?
7. Neuroprotection by encephalomyelitis and neurotrophin production by CNS-infiltrating T and natural killer cells
8. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration
9. MIP-1α, MCP-1, GM-CSF, TNF-α control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord
10. Axon growth promoting and inhibitory molecules involved in the adult mammalian central nervous system
11. NI-35/250/Nogo-A: A neurite growth inhibitor restricting structural plasticity and regeneration of nerve fibers in the adule vertebrate CNS
12. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord
13. Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease
14. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: An in situ hybridization study
15. Traumatic spinal cord injury induces nuclear factor-kappa B activation
16. Delayed demyelination and macophage invasion: A candidate for secondary cell damage in spinal cord injury
17. Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor
18. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord
19. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response
20. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury
21. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
22. Cytokine mRNA profiles incontused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis
23. Activated protein C reduces the severity of compression injury in rats by inhibiting activation of leukocytes
24. Systematically administered interleukin-10 reduced tumor necrosis factor alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
25. Inflammatory cytokines within the central nervous system: Sources, function, and mechanism of action
26. Chemokine expression in rat stab wound brain injury
27. Interleukin-10 inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages
28. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of nitric oxide
29. Upregulation of tumor necrosis factor-α transport across the blood barrier after acute compressive spinal cord injury
30. Upregulation of RGS7 may contribute to tumor necrosis factor-induced changes in central nervous function
31. Spinal cord injury induces expression of RGS7 in microglia/macrophages in rats
32. Tumor necrosis factors protect against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis
33. 2+ accumulation
34. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury
35. Circulating antibody against tumor necrosis factor alpha protects rat brain from reperfusion injury
36. Inducible nitric oxide synthase expression after traumatic train injury and neuroprotection with aminoguanidine treatment in rats
37. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage
38. [3H]L-NG-nitroarginine binding after transient focal ischemia and NMDA-induced excitotoxicity in type I and type III nitric oxide synthase null mice
39. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly
40. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice
41. Effects of moderate hypothermia on constitutive and inducible nitric oxide synthase activities after traumatic brain injury
42. iNOS and nitrotyrosine expression after spinal cord injury
43. Temporal and segmental distribution of constitutive and inducible nitric oxide synthases following traumatic spinal cord injury: Effect of aminoguanidine treatment
44. Effects of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-Year follow-up review of 87 cases
45. Detrimental effects of systemic hyperthermia on locomotor function and histopathological outcome after traumatic spinal cord injury in the rat
46. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction
47. Treatment of traumatic brain injury with moderate hypothermia
48. Hypothermia after cardiac arrest: Feasibility and safety of an external cooling protocol
49. Posttraumatic hypothermia is neuroprotective in a model of traumatic brain injury complicated by a secondary hypoxic insult
50. Therapeutic hypothermia in experimental models of traumatic brain injury
51. Effects of moderate hypothermia on leukocyte-endothelium interaction in the rat pial microvasculature after transient middle cerebral artery occlusion
52. Intraischemic hypothermia attenuates neutrophil infiltration in the rat neocortex after focal ischemia-reperfusion injury
53. Posttraumatic hypothermia reduces polymorphonuclear leukocyte accumulation following spinal cord injury in rats
54. Inflammatory reactions at the blood-endothelial interface in actue stroke
55. The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia
56. Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat
57. Effects of moderate hypothermia on IL-1β induced leukocyte rolling and adhesion in pial microcirculation of mice and on proinflammatory gene expression in human cerebral endothelial cells
58. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
59. Staphylococcal enterotoxin B and tumor-necrosis factor-α-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-β and interleukin-10
60. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis
61. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β
62. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury
63. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and independent pathways
64. Production of tumor necrosis factor in spinal cord following traumatic injury in rats
65. IL-10 inhibits nuclear factor-κB/Rel nuclear activity in CD2-stimulated human peripheral T lymphocytes
66. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway
67. Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed
68. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
69. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat
70. Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity
71. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage
72. Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells
73. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes